Bristol-Myers Squibb Company (BMY)

55.89
0.12 0.22
NYSE : Health Care
Prev Close 55.77
Open 55.96
Day Low/High 55.84 / 56.25
52 Wk Low/High 46.01 / 77.12
Volume 3.37M
Avg Volume 13.28M
Exchange NYSE
Shares Outstanding 1.67B
Market Cap 94.27B
EPS 2.70
P/E Ratio 21.27
Div & Yield 1.56 (2.80%)

Latest News

After Snap IPO, SEC Nominee Sees Change in Power Balance

After Snap IPO, SEC Nominee Sees Change in Power Balance

The White House nominee acknowledged meeting with Carl Icahn after he was nominated - but all they talked about was the billionaire insurgent's view on the importance of activist investors.

Stocks Lower as Crude Slump Weighs on Energy Sector

Stocks Lower as Crude Slump Weighs on Energy Sector

Stocks snap a holding pattern to pull lower on Monday afternoon as a crude oil slump weighS on the energy sector.

Dow, Nasdaq Rise as FBI's Comey Confirms Probe of Russia's Election Interference

Dow, Nasdaq Rise as FBI's Comey Confirms Probe of Russia's Election Interference

Stocks move mostly higher on Monday morning as a hearing on Russia's involvement in the U.S. election begins on Capitol Hill.

Biotech Premarket Movers: CytomX, Aevi, Esperion

Biotech Premarket Movers: CytomX, Aevi, Esperion

CytomX Therapeutics, Aevi Genomic Medicine and Esperion Therapeutics were among the biotech stock movers in premarket trading on Monday.

CytomX Soars on Bristol-Myers Partnership

CytomX Soars on Bristol-Myers Partnership

Shares of the biotech, which researches cancer drugs, were up nearly 30% ahead of market's open.

Stock Futures Slip After G20 Meeting Raises Fears of Protectionism

Stock Futures Slip After G20 Meeting Raises Fears of Protectionism

Stock futures move mostly lower on Monday after the weekend's G20 meeting raises fears over protectionist attitudes among the world's largest economies.

European Stocks Drift Lower; Deutsche Bank Falls on Rights Issue Details

European Stocks Drift Lower; Deutsche Bank Falls on Rights Issue Details

European stocks drifted lower Monday following a holiday-thinned trading session in Asia as investors prepare for key inflation and private sector activity data later in the week.

European Stocks Set For Mixed Open: Dollar Slumps in Quiet Asia Trade

European Stocks Set For Mixed Open: Dollar Slumps in Quiet Asia Trade

European stocks are expected to open mixed Monday following a holiday-thinned trading session in Asia as investors prepare for key inflation and private sector activity data later in the week.

Dow, S&P 500 Decline as Health Care Losses Counter Gains

Dow, S&P 500 Decline as Health Care Losses Counter Gains

Wall Street ends a jampacked week little changed as a selloff in health care stocks counters broad gains elsewhere.

Closing Bell: Citi Dumps SeaWorld; U.S. Stocks Churn as Health Care Falls

Closing Bell: Citi Dumps SeaWorld; U.S. Stocks Churn as Health Care Falls

Stocks churn around the flatline to end the week as a selloff in health care counters gains seen elsewhere.

Fired U.S. Attorney Preet Bharara Was Investigating HHS Chief Tom Price - Report

Fired U.S. Attorney Preet Bharara Was Investigating HHS Chief Tom Price - Report

Fired former U.S. Attorney Preet Bharara was investigating stock trades made by Health and Human Services Secretary Tom Price, according to one report.

Broad Gains Overshadow Health Care Losses to Boost Wall Street

Broad Gains Overshadow Health Care Losses to Boost Wall Street

Stocks rise on Friday even as a selloff in health care extends into its second day.

Stocks Creep Lower as Health Care Selloff Extends Into Day 2

Stocks Creep Lower as Health Care Selloff Extends Into Day 2

Stocks creep lower on Friday as a selloff in health care extends into its second day.

Allergan, Schlumberger, Caterpillar: Doug Kass' Views

Allergan, Schlumberger, Caterpillar: Doug Kass' Views

Doug Kass shares his thoughts on Allergan, and says that Caterpillar remains purr-fect for shorting.

Bristol-Myers Squibb To Announce Results For First Quarter 2017 On April 27

Bristol-Myers Squibb To Announce Results For First Quarter 2017 On April 27

Bristol-Myers Squibb Company (NYSE:BMY) will announce results for the first quarter of 2017 on Thursday, April 27, 2017.

Don't Give the Fed Credit for This Bull: Cramer's 'Mad Money' Recap (Thursday 3/9/17)

Don't Give the Fed Credit for This Bull: Cramer's 'Mad Money' Recap (Thursday 3/9/17)

Big market gains were the result of great companies, CEOs and the people behind them -- not just the Fed, says Jim Cramer.

Cramer: Don't Give the Fed Credit

Cramer: Don't Give the Fed Credit

Most of the 10 best stocks of the bull market did it their way.

Bristol-Myers Squibb Appoints Dr. Thomas J. Lynch, Jr., Executive Vice President And Chief Scientific Officer

Bristol-Myers Squibb Appoints Dr. Thomas J. Lynch, Jr., Executive Vice President And Chief Scientific Officer

Bristol-Myers Squibb Company (NYSE:BMY) today announced that it has appointed Dr.

5 Stocks Insiders Are Loading Up On

5 Stocks Insiders Are Loading Up On

Insiders at Bristol-Myers Squibb, SunOpta and three other companies have been scooping up shares of their own stock lately.

Bristol-Myers Squibb To Take Part In Barclays Global Health Care Conference

Bristol-Myers Squibb To Take Part In Barclays Global Health Care Conference

Bristol-Myers Squibb Company (NYSE:BMY) will present at Barclays Global Health Care Conference on Wednesday, March 15, 2017, in Miami.

What You Should Know About OncoSec's IL-12 Melanoma Immunotherapy

What You Should Know About OncoSec's IL-12 Melanoma Immunotherapy

In a 24-week trial of 22 patients, OncoSec saw a 41% response rate

Biotech Stock Mailbag: OncoSec Medical and the Quest to Turn Cold Tumors Hot

Biotech Stock Mailbag: OncoSec Medical and the Quest to Turn Cold Tumors Hot

TheStreet's Adam Feuerstein answers reader questions about biotech stocks.

Bristol-Myers Squibb Announces Dividend

Bristol-Myers Squibb Announces Dividend

The Board of Directors of Bristol-Myers Squibb Company (NYSE:BMY) today declared a quarterly dividend of thirty-nine cents ($0.

Bristol-Myers Squibb To Present Data That Advances Understanding Of Effects Of Immuno-Oncology Therapies On Cancer Biology And Patient Outcomes At AACR 2017

Bristol-Myers Squibb To Present Data That Advances Understanding Of Effects Of Immuno-Oncology Therapies On Cancer Biology And Patient Outcomes At AACR 2017

Bristol-Myers Squibb Company (NYSE: BMY) today announced that new clinical data will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2017 in Washington, D.

Bristol-Myers Squibb Expands Focus On Precision Medicine With Investment And Planned Collaboration With GRAIL On Blood-Based Cancer Screening

Bristol-Myers Squibb Expands Focus On Precision Medicine With Investment And Planned Collaboration With GRAIL On Blood-Based Cancer Screening

Bristol-Myers Squibb Company (NYSE: BMY) announced today its equity investment and plans for a research collaboration with GRAIL Inc.